Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Directa Plus (DCTA) by Steve Moore in ShareProphets
- Avoid Karelian Diamond Resources (CDI) (KDR) by Nigel Somerville in ShareProphets
- Avoid Hays (HAS) by Steve Moore in ShareProphets
- Watch BP (BP.) by Andrew Mackie in The Motley Fool
- Hold Taylor Wimpey (TW.) by Simon Watkins in The Motley Fool
- Neutral Tate & Lyle (TATE) by Goldman Sachs
- Hold Renishaw (RSW) by Deutsche Bank
- Buy Gooch & Housego (GHH) by Deutsche Bank
- Buy Oxford Nanopore Technologies (ONT) by Berenberg
- Sell Liontrust Asset Management (LIO) by Deutsche Bank
- Buy Flutter Entertainment (DI) (FLTR) by Deutsche Bank
- Buy Polar Capital Holdings (POLR) by Deutsche Bank
- Hold Pearson (PSON) by Deutsche Bank
- Hold Rathbones Group (RAT) by Deutsche Bank
- Buy Hikma Pharmaceuticals (HIK) by Deutsche Bank
- Buy Hays (HAS) by Deutsche Bank
- Buy WPP (WPP) by Deutsche Bank
- Neutral Shell (SHEL) by Citi
- Buy BP (BP.) by Citi
- Underweight GSK (GSK) by Morgan Stanley
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,440 open tips for GSK (GSK)
| Latest Bid : 2,174.00p | Latest Ask : 2,176.00p |
| High Today : 2,196.00p | Low Today : 2,167.42p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 4,217,403 | MKT Cap : £90195.2M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Underweight | Morgan Stanley | Premium Only | 2026-03-02 07:16:00 02/03/2026 | 0.82% |
| Underweight | Barclays | Premium Only | 2026-02-20 05:50:00 20/02/2026 | 2.73% |
| Hold | Berenberg | Premium Only | 2026-02-17 05:42:00 17/02/2026 | -0.91% |
| Hold | Deutsche Bank | Premium Only | 2026-02-13 07:30:00 13/02/2026 | 0.18% |
| Buy | Jefferies | Premium Only | 2026-02-13 04:49:00 13/02/2026 | 0.18% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Millennium International Management LP | 0.51% | 22/01/2026 |
| Latest Bid : 2,174.00p | Latest Ask : 2,176.00p |
| High Today : 2,196.00p | Low Today : 2,167.42p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 4,217,403 | MKT Cap : £90195.2M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Underweight | Morgan Stanley | Premium Only | 2026-03-02 07:16:00 02/03/2026 | 0.82% |
| Underweight | Barclays | Premium Only | 2026-02-20 05:50:00 20/02/2026 | 2.73% |
| Hold | Berenberg | Premium Only | 2026-02-17 05:42:00 17/02/2026 | -0.91% |
| Hold | Deutsche Bank | Premium Only | 2026-02-13 07:30:00 13/02/2026 | 0.18% |
| Buy | Jefferies | Premium Only | 2026-02-13 04:49:00 13/02/2026 | 0.18% |